Nephrology Times

11/14/2025

Our coverage continues to roll out. Next up is our interview with Vlado Perkovic on the possibility of curing and his take on the FINE-ONE and ORIGIN-3 trials presented on day 1 of the meeting.

At ASN Kidney Week 2025, Drs. Joel Topf and Vlado Perkovic discussed curing kidney disease and high-impact trials in diabetic kidney disease and IgA nephropathy (IgAN).

11/14/2025

ICYMI: KidneyCure, the philanthropic arm of ASN, will invest up to $6M in grants over 3 years to support kidney research.

KidneyCure, the philanthropic foundation of the American Society of Nephrology (ASN), will invest $6 million in research grants to support kidney researchers affected by NIH cuts.

11/13/2025

Don't miss part 2 of highlights from Drs. Joel Topf and Anna Gaddy.

Nephrology Times board members Joel Topf, MD, and Anna Gaddy, MD, met at American Society of Nephrology (ASN) Kidney Week 2025 in Houston to discuss day 2's highlights.

11/13/2025

🚨 Attention professionals! 🚨
Registration is now OPEN for the National Kidney Foundation 2026 Spring Clinical Meetings!
Take advantage of early bird discounted rates and explore the latest in clinical research, patient care, and professional development in .
Learn More: https://buff.ly/kUaFRkW

11/12/2025

How would you discuss prognosis in advanced kidney disease with a patient? Five nephrologists share their opinions.

In this recurring section, Nephrology Times asked five nephrologists: How do you discuss prognosis in advanced kidney disease?

11/12/2025

Miss out on ? Catch up with day 1's highlights courtesy of Drs. Joel Topf and Anna Gaddy.

Nephrology Times board members Joel Topf, MD, and Anna Gaddy, MD, met at American Society of Nephrology (ASN) Kidney Week 2025 in Houston to discuss day 1's highlights.

11/11/2025

One of the surprises of ASN Kidney Week was the PISCES trial presentation, showing that there may be a simple way to greatly improve CV outcomes in hemodialysis.

PISCES trial data presented at Kidney Week 2025 showed that daily fish oil supplements lowered the rate of serious cardiovascular events for patients on maintenance hemodialysis.

11/11/2025

Sarah Tolson shares an example of how to challenge claim denials when all avenues involving the payer have been exhausted.

In her column, Sarah Tolson examines when and how to escalate a payer dispute beyond the payer itself.

11/10/2025

Editorial chair Dr. Ajay Singh discusses how removing race from eGFR equations turned conviction into conduct and gave Black transplant candidates fairer access to kidney transplantation.

OPTN policies to correct racial inequities, including adopting the race-free equation for estimating glomerular filtration rate, are giving Black kidney transplant candidates hope.

11/09/2025

WHEW! ASN wraps up today, kicking off with a talk on xenotransplantation and wrapping up with a special session on the IOTA Model. DON'T FORGET to check our website for more coverage. https://buff.ly/QSx7hWD

Review highlights from abstracts and presentations at ASN Kidney Week 2025, presented by the American Society of Nephrology, on Nephrology Times

11/08/2025

✈️ We're heading home from ASN but can't wait to share more from the event with you. Keep an eye on our website for Dr. Joel Topf's interviews with presenters.

Review highlights from abstracts and presentations at ASN Kidney Week 2025, presented by the American Society of Nephrology, on Nephrology Times

11/06/2025

We had a wonderful day at ASN Kidney Week, where Joel Topf interviewed presenters Vlado Perkovic, Jai Radhakrishman, Brad Rovin, and Rajiv Agarwal, and spoke with Anna Gaddy, who will be joining the Nephrology Times board, about the day’s highlights. Keep an eye on nephtimes.com for the videos.